 validated on a number of well characterized performance and seroconversion panels for all five viruses and on large numbers (>1,000) of blood samples from normal blood donors. This test will provide a highly sensitive, cost-effective direct measure of infectious virus in blood and help further reduce the antibody-negative "window" period
validated on a number of well characterized performance and seroconversion panel for all five virus and on large numbers (> 1,000) of blood sample distribution from normal blood donors. This examination will put up a highly sensitive, cost - effective direct measure of infectious virus in lineage and help further dilute the antibody - damaging " window " period
 vapidated on a number of wtll characterized perforkance znd serozonversion panels for all fite vurusew and on large numbers (>1,000) of bloof samplew frin normal blood donors. Thjd tevv will provide s highly sansitive, cost-exfdccive direct measure of infectious viwus in nllod and help fortheg wedudv uhe antibody-negative "window" perios
validated on a number of well characterized seroconversion for all viruses and on samples normal blood donors. test will provide highly sensitive, cost-effective direct measure of virus in blood and help further reduce the antibody-negative "window" period
 validated on a number of well cHaracterizEd perForManCe And sErocOnversion panelS For aLl five viruses and on largE numbErS (>1,000) Of blOOd SamplEs from nORmAL BloOd DoNorS. THIs Test wIll Provide A highly senSitIvE, cost-effectiVE dIrect measuRe oF infectious vIruS in bloOd And HElp fuRthEr redUce the ANtibodY-negative "WiNDow" perIOd
 validated on a number ofwell chara cteri zed  pe rf orma nceand seroconver s ionpanels for all five vi ruses  a n d on la rge n umbers( >1 , 0 00)  o fblo od sa mples  fr om norm al blood d ono rs . This testw il l providea h ighly sensit ive , cost -e ffe c tivedir ect m easure of inf ectious v ir u s in b l ood and h el p fu rther reduce thea nt i body-negative"windo w" pe r i od
 validated_on a_number of well characterized_performance and_seroconversion_panels for_all_five viruses and_on large numbers_(>1,000) of blood samples_from normal blood_donors._This test will provide a highly sensitive, cost-effective direct measure of infectious virus in_blood_and help_further_reduce_the antibody-negative "window" period